SCHEMBL17875848

SCHEMBL17875848

c1ccc2c(c1)oc1ccc(-c3ccc4c(c3)-c3ccc(-c5cccc6oc7ccccc7c56)cc3COC4)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.36
HSP90AA1 P07900 2/20 0.35
HSP90AB1 P08238 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
PLA2G10 O15496 1/20 0.33
PRKDC P78527 1/20 0.32
AHR P35869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875839 1.00 ALOX5 (0.36) ALOX5HSP90AA1HSP90AB1SMN1; SMN2KDM4E
SCHEMBL17875899 0.95 ALOX5 (0.39) ALOX5HSP90AA1HSP90AB1SMN1; SMN2KDM4E
SCHEMBL17875847 0.94 HSP90AA1 (0.38) ALOX5HSP90AA1SMN1; SMN2KDM4EALDH1A1
SCHEMBL17875845 0.93 PRKDC (0.39) ALOX5HSP90AA1SMN1; SMN2KDM4EMEN1
SCHEMBL17875834 0.93 PRKDC (0.39) ALOX5HSP90AA1SMN1; SMN2KDM4EMEN1
SCHEMBL17875838 0.92 MAPT (0.41) ALOX5HSP90AA1HSP90AB1SMN1; SMN2KDM4E
SCHEMBL17875829 0.90 ALOX5 (0.49) ALOX5HSP90AA1PRKDCBACE1
SCHEMBL17875850 0.90 PLA2G2A (0.36) ALOX5HSP90AA1SMN1; SMN2MEN1NPC1
SCHEMBL17875859 0.90 PLA2G2A (0.36) ALOX5HSP90AA1SMN1; SMN2MEN1NPC1
SCHEMBL17875842 0.90 ALOX5 (0.49) ALOX5HSP90AA1PRKDCBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885HSP90AA1 4363/4885HSP90AB1 4642/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885HSP90AA1 4363/4885HSP90AB1 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.